Category: What’s New in MS Research

This installment of “What’s New in MS Research” highlights the breadth of that research, as the nine studies reported below examine everything from a possible link between food allergies and MS disease activity, to the promise of stem cell transplantation in people who have not obtained a satisfactory response from multiple disease-modifying therapies (DMTs). Important studies on the potential causes of MS, the role of patient preferences in drug selection and adherence, and other topics also are covered.

This year’s gathering was held in Berlin, Germany, October 10-12, where the findings were presented from hundreds of studies on topics ranging from the safety and effectiveness of investigational medications to the role of diet in controlling symptoms of MS.

Research into the causes, diagnosis, impact, and management of multiple sclerosis (MS) continues to move forward on a broad front and at a rapid pace. While many advances are announced at medical meetings, such as the annual gatherings of the American Academy of Neurology (AAN), American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Consortium of Multiple Sclerosis Centers (CMSC), and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), other findings are reported in medical journals throughout the year.